Login to Your Account

Kosan, Roche End Partnership; Epothilone Goes Back Home

By Donna Young

Monday, October 29, 2007
Kosan Biosciences Inc. and Roche Holding AG ended their five-year collaboration to develop and commercialize epothilones, anticancer agents that inhibit cell division. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription